Share:
Bill Information
Regular Session 2021-2022
Senate Bill 1091
Short Title:
An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.
Prime Sponsor:
Last Action:
Referred to HEALTH AND HUMAN SERVICES, Feb. 23, 2022 [Senate]
Printer's No.:
| Printer's No. | Text | (H) Amendments | (S) Amendments | (H) Fiscal Note | (S) Fiscal Note | Actuarial Note |
|---|---|---|---|---|---|---|
| 1424* |
* denotes current Printer's Number